31060209|t|Legumain Promotes Atherosclerotic Vascular Remodeling.
31060209|a|Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and atherosclerosis formation is not clear. We assessed the expression of legumain in aortic atheromatous plaques and after wire-injury-induced femoral artery neointimal thickening and investigated the effect of chronic legumain infusion on atherogenesis in Apoe-/- mice. We also investigated the associated cellular and molecular mechanisms in vitro, by assessing the effects of legumain on inflammatory responses in HUVECs and THP-1 monocyte-derived macrophages; macrophage foam cell formation; and migration, proliferation, and extracellular matrix protein expression in human aortic smooth muscle cells (HASMCs). Legumain was expressed at high levels in atheromatous plaques and wire injury-induced neointimal lesions in Apoe-/- mice. Legumain was also expressed abundantly in THP-1 monocytes, THP-1 monocyte-derived macrophages, HASMCs, and HUVECs. Legumain suppressed lipopolysaccharide-induced mRNA expression of vascular cell adhesion molecule-1 (VCAM1), but potentiated the expression of interleukin-6 (IL6) and E-selectin (SELE) in HUVECs. Legumain enhanced the inflammatory M1 phenotype and oxidized low-density lipoprotein-induced foam cell formation in macrophages. Legumain did not alter the proliferation or apoptosis of HASMCs, but it increased their migration. Moreover, legumain increased the expression of collagen-3, fibronectin, and elastin, but not collagen-1, in HASMCs. Chronic infusion of legumain into Apoe-/- mice potentiated the development of atherosclerotic lesions, accompanied by vascular remodeling, an increase in the number of macrophages and ASMCs, and increased collagen-3 expression in plaques. Our study provides the first evidence that legumain contributes to the induction of atherosclerotic vascular remodeling.
31060209	0	8	Legumain	Gene	19141
31060209	18	53	Atherosclerotic Vascular Remodeling	Disease	MESH:D066253
31060209	55	63	Legumain	Gene	5641
31060209	127	142	carotid plaques	Disease	MESH:D016893
31060209	157	165	patients	Species	9606
31060209	171	194	carotid atherosclerosis	Disease	MESH:D002340
31060209	196	204	Legumain	Gene	5641
31060209	232	237	human	Species	9606
31060209	252	257	human	Species	9606
31060209	342	350	legumain	Gene	5641
31060209	355	370	atherosclerosis	Disease	MESH:D050197
31060209	425	433	legumain	Gene	19141
31060209	444	464	atheromatous plaques	Disease	MESH:D058226
31060209	571	579	legumain	Gene	19141
31060209	592	605	atherogenesis	Disease	MESH:D050197
31060209	617	621	mice	Species	10090
31060209	731	739	legumain	Gene	19141
31060209	743	755	inflammatory	Disease	MESH:D007249
31060209	780	785	THP-1	CellLine	CVCL:0006
31060209	925	930	human	Species	9606
31060209	968	976	Legumain	Gene	19141
31060209	1009	1029	atheromatous plaques	Disease	MESH:D058226
31060209	1054	1072	neointimal lesions	Disease	MESH:D009059
31060209	1084	1088	mice	Species	10090
31060209	1090	1098	Legumain	Gene	5641
31060209	1132	1137	THP-1	CellLine	CVCL:0006
31060209	1149	1154	THP-1	CellLine	CVCL:0006
31060209	1205	1213	Legumain	Gene	19141
31060209	1225	1243	lipopolysaccharide	Chemical	MESH:D008070
31060209	1271	1304	vascular cell adhesion molecule-1	Gene	7412
31060209	1306	1311	VCAM1	Gene	7412
31060209	1348	1361	interleukin-6	Gene	3569
31060209	1363	1366	IL6	Gene	3569
31060209	1372	1382	E-selectin	Gene	6401
31060209	1384	1388	SELE	Gene	6401
31060209	1401	1409	Legumain	Gene	19141
31060209	1423	1435	inflammatory	Disease	MESH:D007249
31060209	1530	1538	Legumain	Gene	19141
31060209	1639	1647	legumain	Gene	19141
31060209	1688	1699	fibronectin	Gene	2335
31060209	1705	1712	elastin	Gene	2006
31060209	1765	1773	legumain	Gene	19141
31060209	1787	1791	mice	Species	10090
31060209	1823	1846	atherosclerotic lesions	Disease	MESH:D050197
31060209	1872	1882	remodeling	Disease	MESH:D020257
31060209	2027	2035	legumain	Gene	19141
31060209	2068	2103	atherosclerotic vascular remodeling	Disease	MESH:D066253
31060209	Positive_Correlation	MESH:D007249	19141
31060209	Association	MESH:D066253	19141
31060209	Positive_Correlation	19141	6401
31060209	Negative_Correlation	MESH:D008070	19141
31060209	Positive_Correlation	19141	2006
31060209	Positive_Correlation	MESH:D050197	19141
31060209	Positive_Correlation	19141	2335
31060209	Association	MESH:D002340	5641
31060209	Positive_Correlation	MESH:D008070	7412
31060209	Association	MESH:D050197	5641
31060209	Association	MESH:D009059	19141
31060209	Association	MESH:D020257	19141
31060209	Negative_Correlation	19141	7412
31060209	Positive_Correlation	MESH:D016893	5641
31060209	Positive_Correlation	19141	3569
31060209	Positive_Correlation	MESH:D058226	19141

